Medline Inc. (MDLN) vs ResMed Inc. (RMD)

RMD leads on 9 of 11 compared metrics.

A side-by-side comparison of Medline Inc. and ResMed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 26, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Compare

Total return — MDLN vs RMD

growth of $100 · last 1y
MDLN -7.9%RMD -19.7%MDLN compounded faster
8090100110120Start $1002026$92$80
MDLN RMD

MDLN vs RMD: by the numbers

  • MDLN is the larger company ($31.94B vs $28.81B market cap).
  • RMD trades at the lower earnings multiple (19.21 vs 31.21 P/E).
  • RMD converts more revenue to profit (27.44% vs 3.31% net margin).
  • RMD pays a dividend (1.21% yield) while MDLN does not currently pay one.

Which is better, MDLN or RMD?

Metric tally: MDLN 2 · RMD 9

It depends on what you're optimizing for:

ValueRMD(lower P/E)
QualityRMD(higher ROIC)

Metrics side by side

Valuation

MetricMDLNRMD
P/E ratio31.2119.21
Forward P/E22.7916.22
P/S ratio1.075.27
P/B ratio2.764.50
PEG ratio0.72
EV / EBITDA15.2212.99
FCF yield4.89%5.99%

Profitability

MetricMDLNRMD
Gross margin24.04%61.69%
Operating margin7.04%34.28%
Net margin3.31%27.44%
ROE8.55%23.41%
ROIC5.69%19.56%

Dividends

MetricMDLNRMD
Dividend yield1.21%
Payout ratio25.13%

Growth (annualized)

MetricMDLNRMD
Revenue CAGR (5Y)12.37%
EPS CAGR (5Y)17.25%
FCF CAGR (5Y)18.98%
Total return CAGR (5Y)-3.22%

Frequently asked

Which is better, MDLN or RMD?
It depends on your goal. value: RMD (lower P/E); quality: RMD (higher ROIC). Across all compared metrics, RMD leads 9 to 2.
Is MDLN or RMD cheaper?
On trailing earnings, RMD is cheaper: MDLN trades at a 31.21 P/E and RMD at 19.21.
Does MDLN or RMD pay a bigger dividend?
RMD pays a dividend (1.21% yield) while MDLN does not currently pay one.
Is MDLN or RMD more profitable?
RMD runs the higher net margin — MDLN at 3.31% versus RMD at 27.44%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 26, 2026.